| abstract |
A method of treating, reducing, or alleviating a medical condition in a patient is disclosed herein. The method includes administering a drug delivery implant to a patient in need thereof, the drug delivery implant comprising one or more Rock inhibitors, one or more Wnt inhibitors, one or more integrin inhibitors, and/or one or more glycogen synthase kinase-3 (GSK-3) inhibitors, the patient having a medical condition selected from the group consisting of dry eye, glaucoma, lichen planus, arthritis, psoriasis, plantar fasciitis, pars planitis, scleritis, keratitis, chronic meibomian gland inflammation, optic nerve neuritis, uveitis, papillitis, diabetic neural pain, diabetic retinopathy, a cataract, postoperative inflammation, a side effect occurring after refractive surgery, a side effect occurring after corneal transplant, a side effect occurring after retinal detachment surgery, and combinations thereof. The drug administration treats the medical condition, reduces the medical condition symptoms, enhances nerve regeneration, prevents scarring, and/or alleviates the medical condition. |